Literature DB >> 24718307

Human tissue-type plasminogen activator.

E K O Kruithof1, S Dunoyer-Geindre2.   

Abstract

Tissue-type plasminogen activator (t-PA ) plays an important role in the removal of intravascular fibrin deposits and has several physiological roles and pathological activities in the brain. Its production by many other cell types suggests that t-PA has additional functions outside the vascular and central nervous system. Activity of t-PA is regulated at the level of its gene transcription, its mRNA stability and translation, its storage and regulated release, its interaction with cofactors that enhance its activity, its inhibition by inhibitors such as plasminogen activator inhibitor type 1 or neuroserpin, and its removal by clearance receptors. Gene transcription of t-PA is modulated by a large number of hormones, growth factors, cytokines or drugs and t-PA gene responses may be tissue-specific. The aim of this review is to summarise current knowledge on t-PA function and regulation of its pericellular activity, with an emphasis on regulation of its gene expression.

Entities:  

Keywords:  Plasminogen activators; endothelial cells; gene regulation; nervous system

Mesh:

Substances:

Year:  2014        PMID: 24718307     DOI: 10.1160/TH13-06-0517

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  27 in total

1.  Short-chain fatty acids induce tissue plasminogen activator in airway epithelial cells via GPR41&43.

Authors:  Y Imoto; A Kato; T Takabayashi; M Sakashita; J E Norton; L A Suh; R G Carter; A R Weibman; K E Hulse; W Stevens; K E Harris; A T Peters; L C Grammer; B K Tan; K Welch; D B Conley; R C Kern; S Fujieda; R P Schleimer
Journal:  Clin Exp Allergy       Date:  2018-03-24       Impact factor: 5.018

2.  Mechanism of the protective effects of the combined treatment with rhynchophylla total alkaloids and sinapine thiocyanate against a prothrombotic state caused by vascular endothelial cell inflammatory damage.

Authors:  Yunlun Li; Xinya Zhang; Wenqing Yang; Chao Li; Yanjun Chu; Haiqiang Jiang; Zhenzhen Shen
Journal:  Exp Ther Med       Date:  2017-04-18       Impact factor: 2.447

3.  Novel variant fibrinogen γp.C352R produced hypodysfibrinogenemia leading to a bleeding episode and failure of infertility treatment.

Authors:  Masahiro Yoda; Takahiro Kaido; Tomu Kamijo; Chiaki Taira; Yumiko Higuchi; Shinpei Arai; Nobuo Okumura
Journal:  Int J Hematol       Date:  2021-06-12       Impact factor: 2.490

4.  A Role for Low Density Lipoprotein Receptor-Related Protein 1 in the Cellular Uptake of Tissue Plasminogen Activator in the Lungs.

Authors:  Swan Lin; Jennifer Racz; Melissa F Tai; Kristina M Brooks; Phillip Rzeczycki; Lauren J Heath; Michael W Newstead; Theodore J Standiford; Gus R Rosania; Kathleen A Stringer
Journal:  Pharm Res       Date:  2015-08-01       Impact factor: 4.200

Review 5.  Formation of nasal polyps: The roles of innate type 2 inflammation and deposition of fibrin.

Authors:  Tetsuji Takabayashi; Robert P Schleimer
Journal:  J Allergy Clin Immunol       Date:  2020-03       Impact factor: 10.793

Review 6.  Cytokines in atherosclerosis: Key players in all stages of disease and promising therapeutic targets.

Authors:  Dipak P Ramji; Thomas S Davies
Journal:  Cytokine Growth Factor Rev       Date:  2015-05-12       Impact factor: 7.638

7.  Activities of wild-type and variant tissue-type plasminogen activators retained on vascular endothelial cells.

Authors:  Yuko Suzuki; Hideto Sano; Martyna Tomczyk; Tomasz Brzoska; Tetsumei Urano
Journal:  FEBS Open Bio       Date:  2016-04-01       Impact factor: 2.693

8.  Effect of Regulatory Element DNA Methylation on Tissue-Type Plasminogen Activator Gene Expression.

Authors:  Sylvie Dunoyer-Geindre; Anne-Sophie Rivier-Cordey; Carlos Caetano; Richard J Fish; Egbert K O Kruithof
Journal:  PLoS One       Date:  2016-12-14       Impact factor: 3.240

9.  Plasma tPA-Activity and Progression of Cerebral White Matter Hyperintensities in Lacunar Stroke Patients.

Authors:  Ellen C van Overbeek; Julie Staals; Iris L H Knottnerus; Hugo ten Cate; Robert J van Oostenbrugge
Journal:  PLoS One       Date:  2016-03-04       Impact factor: 3.240

Review 10.  Improvement of Psychotic Symptoms and the Role of Tissue Plasminogen Activator.

Authors:  Silvia Hoirisch-Clapauch; Antonio E Nardi
Journal:  Int J Mol Sci       Date:  2015-11-18       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.